Long noncoding RNA (lncRNA)-mediated competing endogenous RNA networks provide novel potential biomarkers and therapeutic targets for colorectal cancer
Colorectal cancer (CRC) is the third most common cancer and has a high metastasis and
reoccurrence rate. Long noncoding RNAs (lncRNAs) play an important role in CRC growth …
reoccurrence rate. Long noncoding RNAs (lncRNAs) play an important role in CRC growth …
[HTML][HTML] The role of YWHAZ in cancer: A maze of opportunities and challenges
Y Gan, F Ye, XX He - Journal of cancer, 2020 - ncbi.nlm.nih.gov
Abstract YWHAZ (also named 14-3-3ζ) is a central hub protein for many signal transduction
pathways and plays a significant role in tumor progression. Accumulating evidences have …
pathways and plays a significant role in tumor progression. Accumulating evidences have …
Prognostic biomarkers of cell proliferation in colorectal cancer (CRC): from immunohistochemistry to molecular biology techniques
A Kasprzak - Cancers, 2023 - mdpi.com
Simple Summary This review aims to shed light on the proliferative markers important in the
everyday clinical management of colorectal cancer (CRC), ranging from simple methods of …
everyday clinical management of colorectal cancer (CRC), ranging from simple methods of …
Exosomes miR‐22‐3p derived from mesenchymal stem cells suppress colorectal cancer cell proliferation and invasion by regulating RAP2B and PI3K/AKT pathway
Y Wang, C Lin - Journal of oncology, 2021 - Wiley Online Library
Objective. Exosomes (exo) which contain proteins, microRNAs (miRNAs), and other
bioactive substances can participate in intercellular signal transduction and material …
bioactive substances can participate in intercellular signal transduction and material …
Integrated analysis of lymphocyte infiltration-associated lncRNA for ovarian cancer via TCGA, GTEx and GEO datasets
M Wu, X Shang, Y Sun, J Wu, G Liu - PeerJ, 2020 - peerj.com
Background Abnormal expression of long non-coding RNAs (lncRNA) play a significant role
in the incidence and progression of high-grade serous ovarian cancer (HGSOC), which is a …
in the incidence and progression of high-grade serous ovarian cancer (HGSOC), which is a …
The emerging landscape of long non-coding RNAs in colorectal cancer metastasis
Z Liao, H Nie, Y Wang, J Luo, J Zhou, C Ou - Frontiers in oncology, 2021 - frontiersin.org
Colorectal cancer (CRC) is one of the most common gastrointestinal cancers, with extremely
high rates of morbidity and mortality. The main cause of death in CRC is distant metastasis; it …
high rates of morbidity and mortality. The main cause of death in CRC is distant metastasis; it …
Competing endogenous RNAs (ceRNAs) in colorectal cancer: a review
Colorectal cancer (CRC) is a common type of cancer and the second leading cause of
cancer-related deaths worldwide. Competing endogenous RNAs (ceRNAs) that contain …
cancer-related deaths worldwide. Competing endogenous RNAs (ceRNAs) that contain …
LncRNA NNT‐AS1 promotes non‐small cell lung cancer progression through regulating miR‐22‐3p/YAP1 axis
W He, Y Zhang, S Xia - Thoracic cancer, 2020 - Wiley Online Library
Background Lung cancer is the leading cause of cancer‐related mortality worldwide.
Studies have demonstrated that long noncoding RNA nicotinamide nucleotide …
Studies have demonstrated that long noncoding RNA nicotinamide nucleotide …
Circ‐ACAP2 facilitates the progression of colorectal cancer through mediating miR‐143‐3p/FZD4 axis
G Zhang, Z Liu, J Zhong, L Lin - European Journal of Clinical …, 2021 - Wiley Online Library
Abstract Background Circular RNAs (circRNAs) play crucial roles in multiple cancers,
including colorectal cancer (CRC). Here, we explored the role of circRNA ArfGAP with coiled …
including colorectal cancer (CRC). Here, we explored the role of circRNA ArfGAP with coiled …
MicroRNAs in cancer therapy: Their involvement in oxaliplatin sensitivity/resistance of cancer cells with a focus on colorectal cancer
M Ashrafizadeh, A Zarrabi, K Hushmandi, F Hashemi… - Life sciences, 2020 - Elsevier
The resistance of cancer cells into chemotherapy has restricted the efficiency of anti-tumor
drugs. Oxaliplatin (OX) being an anti-tumor agent/drug is extensively used in the treatment of …
drugs. Oxaliplatin (OX) being an anti-tumor agent/drug is extensively used in the treatment of …